Cargando…

Hepatitis B Virus Reactivation in a Patient with Nonalcoholic Steatohepatitis 41 Months after Rituximab-containing Chemotherapy

Hepatitis B virus (HBV) reactivation occasionally occurs long after immunosuppressive therapy. The characteristics of late HBV reactivation remain unclear. We herein present a case of HBV reactivation in a patient with nonalcoholic steatohepatitis (NASH) more than 3 years after rituximab-containing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Manabu, Abe, Kazumichi, Fujita, Masashi, Okai, Ken, Takahashi, Atsushi, Ohira, Hiromasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395117/ https://www.ncbi.nlm.nih.gov/pubmed/30210131 http://dx.doi.org/10.2169/internalmedicine.1587-18

Ejemplares similares

Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia
por: Hayashi, Manabu, et al.
Publicado: (2018)

Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease
por: Abe, Kazumichi, et al.
Publicado: (2018)

Interleukin‐33/ST2‐Mediated Inflammation Plays a Critical Role in the Pathogenesis and Severity of Type I Autoimmune Hepatitis
por: Abe, Kazumichi, et al.
Publicado: (2019)

Endogenous Endophthalmitis Associated with Pyogenic Liver Abscess Caused by Klebsiella pneumoniae
por: Fujita, Masashi, et al.
Publicado: (2019)

Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis
por: Fujita, Masashi, et al.
Publicado: (2020)

The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy
por: Abe, Kazumichi, et al.
Publicado: (2021)

Changes in platelet levels and prognosis in patients with acute liver failure and late-onset hepatic failure
por: Hayashi, Manabu, et al.
Publicado: (2022)

Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization
por: Fujita, Masashi, et al.
Publicado: (2019)

Association between serum ficolin-1 level and disease progression in primary biliary cholangitis
por: Hayashi, Manabu, et al.
Publicado: (2020)

Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis
por: Hayashi, Manabu, et al.
Publicado: (2022)

Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis
por: Abe, Kazumichi, et al.
Publicado: (2016)

Reduced brain activity in female patients with non-alcoholic fatty liver disease as measured by near-infrared spectroscopy
por: Takahashi, Atsushi, et al.
Publicado: (2017)

Intratumor Abscess in a Posttraumatic Hepatic Inflammatory Pseudotumor Spreading Out of the Liver
por: Hayashi, Manabu, et al.
Publicado: (2020)

Contrast uptake in primary hepatic angiosarcoma on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in the hepatobiliary phase
por: Hayashi, Manabu, et al.
Publicado: (2018)

Sigmoid Colon Varices due to Massive Thrombosis of a Noncirrhotic Extrahepatic Portosystemic Shunt
por: Hayashi, Manabu, et al.
Publicado: (2020)

Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey
por: Takahashi, Atsushi, et al.
Publicado: (2020)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
por: Sumida, Yoshio, et al.
Publicado: (2020)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis
por: Ninomiya, Masashi, et al.
Publicado: (2012)

MicroRNAs and Nonalcoholic Steatohepatitis: A Review
por: Morishita, Asahiro, et al.
Publicado: (2023)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Correction: Medaka as a model for human nonalcoholic steatohepatitis
por: Matsumoto, Toshihiko, et al.
Publicado: (2023)

Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
por: Kessoku, Takaomi, et al.
Publicado: (2016)

High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis
por: Kawanaka, Miwa, et al.
Publicado: (2019)

Plasma Fatty Acid Composition Is Associated with Histological Findings of Nonalcoholic Steatohepatitis
por: Miyake, Teruki, et al.
Publicado: (2022)

Hepatic gene expression and functional changes associated with nonalcoholic steatohepatitis
por: Matsumoto, Kana, et al.
Publicado: (2022)

Wilson's disease masquerading as nonalcoholic steatohepatitis
por: Mahmood, Sabina, et al.
Publicado: (2009)

Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
por: Lam, Mindy C.W., et al.
Publicado: (2012)

The effect of β-caryophyllene on nonalcoholic steatohepatitis
por: Arizuka, Naoya, et al.
Publicado: (2017)

New Aspects of Lipotoxicity in Nonalcoholic Steatohepatitis
por: Mendez-Sanchez, Nahum, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rbkr7nq7cpmf35ju0rs4tfqgo2